Heteroaryl and benzyl amide compounds

Abstract
Compounds of formula I
Description
Claims
  • 1. A compound of formula I
  • 2. The compound according to claim 1 wherein R1 is C1-C6alkyl, halo-C1-C6alkyl, C3-C8cycloalkyl, halo-C3-C8cycloalkyl or tri-C1-C6alkylsilyl.
  • 3. The compound according to claim 1 wherein R2 is a group (a).
  • 4. The compound according to claim 1 wherein R2 is a group (b).
  • 5. The compound according to claim 1 wherein R1 is C1-C6alkyl, halo-C1-C6alkyl, halo-C1-C6alkoxy, C3-C8cycloalkyl, halo-C3-C8cycloalkyl or tri-C1-C6alkylsilyl;R2 is hydrogen or a group
  • 6. The compound according to claim 1 wherein R1 is C1-C6alkyl, halo-C1-C6alkyl, halo-C1-C6alkoxy, C3-C8cycloalkyl, halo-C3-C8cycloalkyl or tri-C1-C6alkylsilyl;R2 is hydrogen or a group
  • 7. The compound according to claim 1 wherein R1 is C1-C6alkyl, halo-C1-C6alkyl, halo-C1-C6alkoxy, C3-C8cycloalkyl, halo-C3-C8cycloalkyl or tri-C1-C6alkylsilyl;R2 is hydrogen or a group
  • 8. The compound according to claim 1 wherein R1 is C1-C6alkyl;R2 is a group
  • 9. A process for the production of a compound of formula I according to claim 1 which process comprises reacting an acid derivative, a compound of formula II
  • 10. The compound of claim 5 wherein R2 is
  • 11. The compound of claim 5 wherein R2 is
  • 12. The compound of claim 6 wherein R2 is
  • 13. The compound of claim 6 wherein R2 is
  • 14. The compound of claim 7 wherein R2 is
  • 15. The compound of claim 7 wherein R2 is
  • 16. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier or adjuvant or mixture thereof.
Priority Claims (1)
Number Date Country Kind
06101370.2 Feb 2006 EP regional